Kennedy Capital Management LLC Grows Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Kennedy Capital Management LLC boosted its holdings in Avantor, Inc. (NYSE:AVTR) by 50.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 79,483 shares of the company’s stock after buying an additional 26,814 shares during the period. Kennedy Capital Management LLC’s holdings in Avantor were worth $2,032,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Graypoint LLC grew its stake in Avantor by 3.8% in the 1st quarter. Graypoint LLC now owns 11,414 shares of the company’s stock valued at $292,000 after buying an additional 423 shares in the last quarter. Vontobel Holding Ltd. grew its stake in Avantor by 2.0% in the 4th quarter. Vontobel Holding Ltd. now owns 30,215 shares of the company’s stock valued at $690,000 after buying an additional 591 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its stake in Avantor by 3.8% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,725 shares of the company’s stock valued at $427,000 after buying an additional 685 shares in the last quarter. Fifth Third Bancorp boosted its holdings in Avantor by 125.3% in the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares during the period. Finally, Mackenzie Financial Corp boosted its holdings in Avantor by 1.6% in the 4th quarter. Mackenzie Financial Corp now owns 46,610 shares of the company’s stock valued at $1,064,000 after purchasing an additional 747 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Trading Down 0.7 %

Avantor stock traded down $0.20 during mid-day trading on Wednesday, hitting $27.45. The company’s stock had a trading volume of 2,583,239 shares, compared to its average volume of 6,963,523. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05. The stock has a market cap of $18.66 billion, a price-to-earnings ratio of 70.90, a price-to-earnings-growth ratio of 2.70 and a beta of 1.32. The business has a 50 day moving average price of $22.47 and a 200-day moving average price of $23.71. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $27.99.

Analyst Upgrades and Downgrades

Several brokerages have commented on AVTR. Evercore ISI cut their price target on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Robert W. Baird raised their price target on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a report on Monday. Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and cut their price target for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Royal Bank of Canada reissued an “outperform” rating and issued a $31.00 price target on shares of Avantor in a report on Monday. Finally, Stifel Nicolaus raised their price target on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $27.21.

Insiders Place Their Bets

In other Avantor news, insider Christophe Couturier 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.